Overview

In this new consolidated guidelines document on HIV prevention, diagnosis, treatment and care for key populations, the World Health Organization brings together all existing guidance relevant to five key populations – men who have sex with men, people who inject drugs, people in prisons and other closed settings, sex workers and transgender people – and updates selected guidance and recommendations.

These guidelines aim to:

• provide a comprehensive package of evidence-based HIV-related recommendations for all key populations;
• increase awareness of the needs of and issues important to key populations;
• improve access, coverage and uptake of effective and acceptable services; and
• catalyze greater national and global commitment to adequate funding and services.

Contents

• ACKNOWLEDGEMENTS
• ABBREVIATIONS AND ACRONYMS
• DEFINITIONS OF KEY TERMS
• EXECUTIVE SUMMARY
• 1. INTRODUCTION
  • 1.1. Key populations and vulnerable groups
  • 1.2. HIV in key populations
  • 1.3. Addressing key populations: a wise investment
  • 1.4. Scope of these key population guidelines
  • 1.5. Using these guidelines
  • 1.6. Goal and objectives
  • 1.7. Target audience
  • 1.8. Guidelines principles
• 2. METHODOLOGY AND PROCESS FOR DEVELOPMENT OF THE GUIDELINES
  • 2.1. Overview
  • 2.2. Establishing guideline groups
  • 2.3. Defining the scope of the guidelines
  • 2.4. Review of the evidence
  • 2.5. Development of the pre-exposure prophylaxis recommendations
  • 2.6. Evidence assessment
  • 2.7. Review of service delivery, implementation approaches and case studies
  • 2.8. Producing the guidelines
  • 2.9. Plans for dissemination
  • 2.10. Updating
• 3. COMPREHENSIVE PACKAGE OF INTERVENTIONS
  • 3.1. Services for all key populations
  • 3.2. Specific considerations
• 4. HEALTH SECTOR INVERVENTIONS
  • 4.1. Prevention
  • 4.2. HIV testing and counselling
  • 4.3. Linkage and enrolment in care
  • 4.4. HIV treatment and care
  • 4.5. Prevention and management of coinfections and co-morbidities
  • 4.6. General care
• 5. CRITICAL ENABLERS
  • 5.1. Law and policy
  • 5.2. Stigma and discrimination
  • 5.3. Community empowerment
  • 5.4. Violence
• 6. SERVICE DELIVERY
  • 6.1. Overview
  • 6.2. Key service delivery strategies
  • 6.3. Key factors to consider when providing services for all key populations
• 7. DEVELOPING THE RESPONSE: THE DECISION-MAKING, PLANNING AND MONITORING PROCESS
  • 7.1. Introduction
  • 7.2. Understanding the situation
  • 7.3. Planning and implementing the response
  • 7.4. Monitoring and evaluating the response
  • 7.5. Ongoing planning and development of the response
• REFERENCES
• ANNEXES
  • Annex 1. Pre-exposure prophylaxis for men who have sex with men: a systematic review
    Caitlin Kennedy and Virginia Fonner.
  • Annex 2. Pre-exposure prophylaxis for people who inject drugs: a systematic review
    Caitlin Kennedy and Virginia Fonner.
  • Annex 3. Values and preferences
  • Annex 4. Health interventions in prisons: a literature review
    Amee Schwitters.
  • Annex 5. Case examples of programmes serving the needs of key populations
    Mary Henderson.
  • Annex 6. Briefs on young key populations
  • Annex 7. Recommendation on ARV-related prevention: Language from 2014 version of the Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.